Evidence map›Paper›PMID 34427788›Full record

Trial reportJournal of cancer research and clinical oncology2021

Interactions of occult tumor spread and surgical technique on overall and disease-free survival in patients operated for stage I and II right-sided colon cancer.

G S Banipal, B V Stimec, S N Andersen, A E Faerden, B Edwin, J Baral, J Šaltytė Benth, D Ignjatovic, RCC study group

Registry-linked trialOpen access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Journal of cancer research and clinical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01351714 (Safe D3 Right Hemicolectomy for Cancer Through 3D MDCT Angiography Reconstruction), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01351714 naunknown statusnot on this map

Safe D3 Right Hemicolectomy for Cancer Through 3D MDCT Angiography Reconstruction

TypeinterventionalSponsorSykehuset i Vestfold HFRan2011 to 2021Enrolled700ConditionsColon CancerArmsD3 resection
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

G S BanipalDepartment of Digestive Surgery, Akershus University Hospital HF, Postboks 1000, 1478, Lorenskog, Norway. gurpreet.singh.banipal@ahus.no.ORCID http://orcid.org/0000-0001-7700-5430
B V StimecAnatomy Sector, Teaching Unit, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
S N AndersenDepartment of Pathology, Akershus University Hospital HF, Postboks 1000, 1478, Lorenskog, Norway.
A E FaerdenDepartment of Digestive Surgery, Akershus University Hospital HF, Postboks 1000, 1478, Lorenskog, Norway.
B EdwinInterventional Centre and Department of HPB Surgery, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
J BaralDepartment of Colorectal Surgery, Klinikum Karlsruhe, Karlsruhe, Germany.
J Šaltytė BenthInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
D IgnjatovicDepartment of Digestive Surgery, Akershus University Hospital HF, Postboks 1000, 1478, Lorenskog, Norway.
RCC study group
University of Oslo · NOAkershus University Hospital · NOOslo School of Architecture and Design · NOOslo University Hospital · NOStädtisches Klinikum Karlsruhe · DEUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo determine if "medial to lateral" (ML) dissection with devascularization first is superior to "lateral to medial" (LM) dissection regarding numbers of lymph node micro metastases (MM) and isolated tumor cells (ITC) as well as 5-year disease-free (5YDFS) and 5-year overall survival (5YOS) in stage I/II right-sided colon cancer.

methodsTwo datasets are used. ML group consists of consecutive stage I/II patients from a prospective trial. LM group is the original dataset from a previous publication. All harvested lymph nodes are examined with monoclonal antibody CAM 5.2 (immunohistochemically). Lymph node harvest and 5YOS/5YDFS were compared between ML/LM groups, stage I/II tumors and MM/ITC presence/absence.

results117 patients included ML:51, LM:66. MM/ITC positive in ML 37.3% (19/51), LM 31.8% (21/66) p = 0.54. The 5YDFS for patients in ML 70.6% and LM 69.7%, p = 0.99, 5YOS: 74.5% ML and 71.2% LM (p = 0.73). No difference in 5YDFS/5YOS between groups for Stage I/II tumors; however, LM group had an excess of early tumors (16) when compared to ML group, while lymph node harvest was significantly higher in ML group (p < 0.01) 15.1 vs 26.7. 5YDFS and 5YOS stratified by MM/ITC presence/absence was 67.5%/71.4%, p = 0.63, and 75.0%/71.4%, p = 0.72, respectively. Death due to recurrence in MM/ITC positive was significantly higher than MM/ITC negative (p = 0.012).

conclusionSurgical technique does not influence numbers of MM/ITC or 5YDFS/5YOS. Presence of MM/ITC does not affect 5YOS/5YDFS but can be a potential prognostic factor for death due to recurrence. CLINICAL TRIAL: Safe Radical D3 Right Hemicolectomy for Cancer through Preoperative Biphasic Multi-Detector Computed Tomography (MDCT) Angiography" registered at http://clinicaltrials.gov/ct2/show/NCT01351714 .

Indexed as

AgedColectomyColonic NeoplasmsDisease-Free SurvivalFemaleHumansLaparotomyLymphatic MetastasisMaleMiddle AgedD3 right colectomyIsolated tumor cellsMicro metastasesOccult tumor spreadStage I/II right-side colon cancer

Identifiers

PMID34427788
PMCPMC8557178
OpenAlexW3193849286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.